A practical conversation on how biotechs can read RFPs differently, avoid the fluency trap, challenge assumptions, and choose vendors that can actually deliver.

Every biotech faces this moment: the RFP looks perfect, polished, aligned, convincing. But does it actually signal readiness?

In this episode, Seuss+ CEO Kieran Engels joins Julia Vassiliadou (F2G) to break down why a beautiful proposal can mislead sponsors, what real signals of vendor readiness look like, and how biotechs can tailor the selection process to avoid costly mistakes.

Together, they unpack:

Why we confuse polish with capabilityThe four signals that a vendor is genuinely readyHow to challenge assumptions during bid defensesWhy risk-based thinking (ICH E6 R3) should shape sponsor decision-makingHow governance, oversight, and setup determine long-term CRO successWhether you’re selecting your first CRO or refining your next vendor strategy, this conversation gives you the tools to see beyond the surface and choose smarter.

🎧 Listen now and don’t let polish fool you.

Episode ID: 1000741366186

GUID: d342c6df-e83c-4a20-905e-18eb0e1efb81

Release Date: 15/12/2025, 18:30:10